FDA-approved TNKase is available at OhioHealth Shelby Hospital for the treatment of acute ischemic stroke for adults.

The FDA approved tenecteplase (TNKase) for adult stroke patients, Genentech announced on Monday. A clot-dissolving tissue ...

We have seen 1 institutional investors add shares of $TNK stock to their portfolio, and 151 decrease their positions in their most recent quarter.